| 发明名称 |
GENETIC MARKERS FOR PREDICTING RESPONSIVENESS TO THERAPY WITH HDL-RAISING OR HDL MIMICKING AGENT |
| 摘要 |
The present invention provides genotyping methods and compositions for selecting patients with cardiovascular disease who will benefit from treatment with HDL-raising or HDL mimicking agent, in particular with a CETP inhibitor/modulator |
| 申请公布号 |
WO2016016157(A1) |
申请公布日期 |
2016.02.04 |
| 申请号 |
WO2015EP67098 |
申请日期 |
2015.07.27 |
| 申请人 |
F. HOFFMANN-LA ROCHE AG;HOFFMANN-LA ROCHE INC. |
发明人 |
DUBÉ, MARIE-PIERRE;TARDIF, JEAN-CLAUDE |
| 分类号 |
C12Q1/68 |
主分类号 |
C12Q1/68 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
